Nigeria

Resilience System


You are here

Analysis

Israeli hospital: 98% of staff who got 2nd shot have high-level COVID antibodies

A new serological study conducted at Sheba Medical Center in Ramat Gan has shown 98% of hospital workers who received the second dose of the coronavirus vaccine have developed a high level of antibodies to fight off the virus.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Study: In pandemic era, older adults isolated but resilient

Since the pandemic’s descent, they have generally been viewed as among those at higher risk — older Americans, some of them medically vulnerable, figuring out how to navigate life in a COVID-saturated, increasingly isolated world.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Study: The Future of the Coronavirus? An Annoying Childhood Infection

As millions are inoculated against the coronavirus, and the pandemic’s end finally seems to glimmer into view, scientists are envisioning what a post-vaccine world might look like — and what they see is comforting.

The coronavirus is here to stay, but once most adults are immune — following natural infection or vaccination — the virus will be no more of a threat than the common cold, according to a study published in the journal Science on Tuesday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

RESEARCH: A mutation undercuts the immune response to the COVID virus

NATURE

A mutation undercuts the immune response to the COVID virus 

A handful of mutations to SARS-CoV-2 can help it to escape the immune response mounted by a subset of infected people.

Researchers have identified thousands of mutations in SARS-CoV-2 samples, but the vast majority are unlikely to have much effect on the virus’s biology. To identify potentially important mutations, Jesse Bloom at the Fred Hutchinson Cancer Research Center in Seattle, Washington, and his colleagues studied antibodies against SARS-CoV-2 isolated from the blood serum of people who had recovered from COVID-19 (A. J. Greaney et al. Preprint at bioRxiv https://doi.org/ghr85d; 2021).

The team tested the antibodies’ response to samples of the virus’s spike protein. Each sample protein carried different versions of a region called the receptor binding domain (RBD), which recognizes host cells and is a major target for antibodies.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Analysis
howdy folks
Page loaded in 0.787 seconds.